Email this article Database of patients with sarcoidosis of the Republic of Tatarstan: a retrospective analysis for 50 years
- Authors: Vizel A.A.1, Shakirova G.R.1,2, Vizel I.Y.1,3, Kudryavtseva E.Z.4, Burchagina A.S.4, Vorobyova N.B.5, Gizatullina E.D.1, Igonina O.A.6, Rakhimzyanov A.R.1,7, Filatova M.S.8,9, Tsyplenkova R.R.9, Shaimuratov R.I.1
-
Affiliations:
- Kazan State Medical University
- Republican Clinical Hospital
- Central Research Institute of Tuberculosis
- City Clinical Hospital No. 16
- Family clinic Tanar
- Medical Association Salvation
- Kazan Federal University
- Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional Education
- All Republic Clinical Tuberculosis Dispensary
- Issue: Vol 48, No 5 (2020)
- Pages: 291-298
- Section: ARTICLES
- URL: https://almclinmed.ru/jour/article/view/1398
- DOI: https://doi.org/10.18786/2072-0505-2020-48-055
- ID: 1398
Cite item
Full Text
Abstract
Background: Sarcoidosis is a granulomatous disease with no established etiology. The prevalence of sarcoidosis is growing, there are changes in the clinic of the disease depending on geolocation and the environment.
Aim: To analyze the database (register) of sarcoidosis patients registered with this disease in the Republic of Tatarstan.
Materials and methods: In Tatarstan, an electronic database of 2715 patients with sarcoidosis has been created, collected over the past 50 years. The frequencies of the phenomena were estimated, and the ChI-square Pearson criterion was calculated to assess the relationship of events and their reliability.
Results: There were 69.2% of women and 30.8% of men. The average age was 44.2 years (15 to 87 years, median 44 years). Men were younger (median 36 years old) than women (median 48 years old). Most often, there was stage II (47.8%) and stage I (40.8%). Lofgren's syndrome was in 13% of patients. 42% had biopsy data, over three decades its frequency increased -21.9%, 34.8% and 49.0%, respectively. After 2010, there was an increase in stage II sarcoidosis, over the past 20 years, the proportion of women has decreased and the proportion of men has grown. Adverse factors of the profession orthe environment were in every third patient. The frequency of prescribing prednisone decreased from 2013 to 2019 from 23.1% to 9.1%, and pentoxifylline increased from 14.9% in 2011 to 58% in 2019. Every third patient received vitamin E.
Conclusion: About 100 new patients were identified annually. An increase in the II radiation stage of sarcoidosis was noted. A biopsy was performed only on every second patient. The treatment was consistent with the international approach - to use prednisone and cytostatics only with the progression of the process.
Keywords
About the authors
A. A. Vizel
Kazan State Medical University
Author for correspondence.
Email: lordara@inbox.ru
ORCID iD: 0000-0001-5028-5276
Alexander A. Vizel - MD, PhD, Professor, Head of Chair of Phthisiopulmonology.
49 Butlerova ul., Kazan, 420012, Tel.: +7 (987) 296 25 99
Russian FederationG. R. Shakirova
Kazan State Medical University; Republican Clinical Hospital
Email: adeleashakirova02@mail.ru
Gulnaz R. Shakirova - MD, PhD, Assistant, Chair of Phthisiopulmonology Kazan SMU; Pulmonologist, Department of Pulmonology. Republican Clinical Hospital.
49 Butlerova ul., Kazan, 420012; 138 Orenburgskiy trakt, Kazan, 420064; Tel.: +7 (917) 884 30 39
Russian FederationI. Yu. Vizel
Kazan State Medical University; Central Research Institute of Tuberculosis
Email: tatpulmo@mail.ru
Irina Yu. Vizel - MD, PhD, Associate Professor, Chair of Phthisiopulmonology Kazan SMU; Research Fellow CRIT.
49 Butlerova ul., Kazan, 420012; 2 Yauzskaya alleya, Moscow, 107564; Tel.: +7 (917) 903 91 13
Russian FederationE. Z. Kudryavtseva
City Clinical Hospital No. 16
Email: elk-a@inbox.ru
Elvira Z. Kydryavtseva - Head of Department of Pulmonology.
121 Gagarina ul., Kazan, 420039; Tel.: +7 (917) 269 68 88
Russian FederationA. S. Burchagina
City Clinical Hospital No. 16
Email: burchagina.alina@mail.ru
Alina S. Burchagina - Pulmonologist, Department of Pulmonology.
121 Gagarina ul., Kazan, 420039; Tel.: +7 (919) 624 28 65
Russian FederationN. B. Vorobyova
Family clinic Tanar
Email: med9@list.ru
Natalya B. Vorobyova – Pulmonologist.
3A Yunykh Lenintsev bul'var, Naberezhnye Chelny, 423827; Tel.: +7 (917) 294 73 15
Russian FederationE. D. Gizatullina
Kazan State Medical University
Email: gizatullinaelia@yandex.ru
Elvira D. Gizatullina - MD, PhD, Assistant, Chair of Phthisiopulmonology.
49 Butlerova ul., Kazan, 420012
Russian FederationO. A. Igonina
Medical Association Salvation
Email: mashmaut@mail.ru
Olga A. Igonina – Pulmonologist.
47/113 N. Nazarbaeva ul., Kazan, 420059; Tel.: +7 (960) 041 00 69
Russian FederationA. R. Rakhimzyanov
Kazan State Medical University; Kazan Federal University
Email: alfredrr@mail.ru
Alfrit R. Rakhimzyanov - Assistant, Chair of Hygiene and Occupational Medicine Kazan SMU; Senior Teacher, Institute of Fundamental Medicine and Biology Kazan FU.
49 Butlerova ul., Kazan, 420012; 18 Kremlevskaya ul., Kazan, 420008; Tel.: +7 (843) 571 12 97
Russian FederationM. S. Filatova
Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional Education; All Republic Clinical Tuberculosis Dispensary
Email: mariafs@mail.ru
Maria S. Filatova - MD, PhD, Assistant, Chair of Phthisiology and Pulmonology Kazan SMA - Branch Campus RMACPE; Head of Department of Differential Diagnosis All RCTD.
11 Mushtari ul., Kazan, 420012; 1 Pribol'nichnaya ul., Derbyshki poselok, Kazan, 420075; Tel.: +7 (965) 602 07 15
Russian FederationR. R. Tsyplenkova
All Republic Clinical Tuberculosis Dispensary
Email: regina1977@mail.ru
Regina R. Tsyplenkova - Physician, Department of Differential Diagnosis.
1 Pribol'nichnaya ul., Derbyshki poselok, Kazan, 420075; Tel.: +7 (903) 062 58 39 Russian FederationR. I. Shaimuratov
Kazan State Medical University
Email: russtem@gmail.com
Rustem I. Shaimuratov - MD, PhD, Assistant, Chair of Phthisiopulmonology.
49 Butlerova ul., Kazan, 420012; Tel.: +7 (917) 900 55 10
Russian FederationReferences
- Визель АА, ред. Саркоидоз: монография. М.: Атмосфера; 2010. 416 с.
- Brito-Zeron P, Kostov B, Superville D, Baughman RP, Ramos-Casals M; Autoimmune Big Data Study Group. Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants. Clin Exp Rheumatol. 2019;37(6):1052-64.
- Ungprasert P, Ryu JH, Matteson EL. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358-75. doi: 10.1016/jmayocpiqo.2019.04.006.
- Наследов АД. SPSS 15: профессиональный статистический анализ данных. СПб.: Питер; 2008. 416 с.
- Thillai M, Chang W, Chaudhuri N, Forrest I, Ho LP, Lines S, Maher TM, Spencer LG, Spiteri M, Coker R. Sarcoidosis in the UK: insights from British Thoracic Society registry data. BMJ Open Respir Res. 2019;6(1):e000357. doi: 10.1136/bmjre-sp-2018-000357.
- Fidler LM, Balter M, Fisher JH, To T, Stanbrook MB, Gershon A. Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study. Eur Respir J. 2019;54(4):1900444. doi: 10.1183/13993003.00444-2019.
- Слепова РИ, Галиаскарова ЭР, Домрачева ОВ. Роль фтизиатрической службы в выявлении и лечении больных саркоидозом. В: Адамович ВН. Дифференциальная диагностика саркоидоза и туберкулеза легких. М.; 1988. с. 16-9.
- Bogdan M, Nitsch-Osuch A, Kanecki K, Gorynski P, Tyszko P, Baranska A, Samel-Kowalik P. Sarcoidosis among hospitalized patients in Poland: a study based on a National hospital registry. Pol Arch Intern Med. 2019;129(9): 580-5. doi: 10.20452/pamw.14927.
- Markevitz N, Epstein Shochet G, Levi Y, Israeli-Shani L, Shitrit D. Sarcoidosis in Israel: Clinical Outcome Status, Organ Involvement, and Long-Term Follow-Up. Lung. 2017;195(4): 419-24. doi: 10.1007/s00408-017-0015-4.
Supplementary files
